Neogen | NEOG - Cash And Equivalent


Neogen reported $159.9M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Agilent USD 1.81B 49M Mar/2026
Avanos Medical USD 65.6M 24.2M Mar/2026
Bio-Rad Laboratories USD 507.2M 22.6M Mar/2026
Cerus USD 19.96M 4.29M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Idexx Laboratories USD 200.53M 20.46M Mar/2026
Illumina USD 1.42B 368M Dec/2025
Integra LifeSciences USD 236.81M 1.76M Mar/2026
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 176.96M 22.31M Mar/2026
Pacific Biosciences Of California USD 56.27M 223.23M Mar/2026
Quidel USD 140.4M 29.4M Mar/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Utah Medical Products USD 84.27M 2.09M Sep/2025
Zoetis USD 1.94B 369M Mar/2026